![Pharmacy | Free Full-Text | Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs | HTML Pharmacy | Free Full-Text | Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs | HTML](https://www.mdpi.com/pharmacy/pharmacy-06-00010/article_deploy/html/images/pharmacy-06-00010-g001.png)
Pharmacy | Free Full-Text | Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs | HTML
![Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11883-020-0823-5/MediaObjects/11883_2020_823_Fig2_HTML.png)
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink
![Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrendo.2009.151/MediaObjects/41574_2009_Article_BFnrendo2009151_Fig1_HTML.jpg)
Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology
![Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11883-020-0823-5/MediaObjects/11883_2020_823_Fig1_HTML.png)
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink
![Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases. - Abstract - Europe PMC Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6514171/bin/jat-26-389-g004.jpg)